Biography

Dr. Ibrahim Hamdy Younos is currently working as Assistant Professor in Pharmacology and Clinical Pharmacy Department, School of Medicine & Health Sciences Sultan Qabus University, Oman, and Lecturer in Clinical Pharmacology Department, Faculty of Medicine, Minufiya University, Egypt. He obtained his PhD in Basic Biomedical Sciences from University of Nebraska Medical Center, Omaha, NE, USA in 2011, and MBBCh, Medicine and Surgery from School of Medicine, Minufiya University, Minufiya, Egypt in 1997. In past he worked as House Officer, Minufiya University Hospital, Minufiya, Egypt, General Practitioner & Family Medicine, Ministry of Health & Population, Demonstrator and Assistant Lecturer at Minufiya University, Postdoctoral Fellow at Lee Moffitt Cancer Center, Tampa, FL, USA. He is member of following scientific societies, American Association of Cancer Research, American Society for Pharmacology and Experimental Therapeutics, Egyptian Society of Pharmacology & Experimental Therapeutics. He is also a member of editorial board and reviewer of journals. Dr. Ibrahim Hamdy received honors include Postdoctoral Fellowship, Experimental PhD Graduate Fellowship from the Ministry of Higher Education, Egypt, TEMPUS-sponsored Fellowship, WHO Fellowship to attend the International PRDU Training Course for Best Research Project Proposal Award, Pakistan. He is also invited as speaker in foreign countries. He has published 16 articles in journals as author/co-author.

Area of Interest:

Pharmacology and Toxicology

100%

Clinical Pharmacology

62%

Cancer Immunotherapy

90%

Immunology

75%

Physiology

55%

Research Publications in Numbers

Books
0

Chapters
0

Articles
0

Abstracts
0

Selected Publications

Gibney, G.T., R.R. Kudchadkar, R.C. DeConti, M.S. Thebeau and M.P. Czupryn et al., 2015. Correlative markers and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma. Clin. Cancer Res., Vol. 21. .
Younos, I.H., A.J. Dafferner, H. Britton and J.E. Talmadge, 2013. Multidimensional crosstalk regulates myeloid cell hyperplasia, immune escape, and tumor progression. Cancer Res., Vol. 73. .
Direct Link |
Gibney, G.T., J.S. Weber, R.R. Kudchadkar, R.C. de Conti and L. Tetteh et al., 2013. Safety and efficacy of adjuvant anti-PD1 therapy (nivolumab) in combination with vaccine in resected High-risk metastatic melanoma. J. Clin. Oncol., Vol. 31. .
Direct Link |
Younos, I.H., A.J. Dafferner, D. Gulen, H.C. Britton and J.E. Talmadge, 2012. Tumor regulation of Myeloid-derived suppressor cell proliferation and trafficking. Int. Immunopharmacol., 13: 245-256.
CrossRef | Direct Link |
Gulen, D., S. Maas, H. Julius, P. Warkentin and H. Britton et al., 2012. Cryopreservation of Adenovirus-transfected dendritic cells (DCs) for clinical use. Int. Immunopharmacol., 13: 61-68.
CrossRef | PubMed | Direct Link |
Younos, I., M. Donkor, T. Hoke, A. Dafferner, H. Samson, S. Westphal and J. Talmadge, 2011. Tumor- and organ-dependent infiltration by Myeloid-derived suppressor cells. Int. Immunopharmacol., 11: 816-826.
CrossRef | Direct Link |
Abe, F., I. Younos, S. Westphal, H. Samson and E. Scholar et al., 2010. Therapeutic activity of sunitinib for Her2/neu induced mammary cancer in FVB mice. Int. Immunopharmacol., 10: 140-145.
CrossRef | PubMed | Direct Link |
Mohamad, I.A., I.A. Mohamad and H.Y. Ibrahim, 2005. Harpagophytum procumbens (Devil's Claw): A possible natural anti-inflammatory agent (An Experimental Study). Iran. J. Pharmacol. Therapeut., 4: 54-63.
Direct Link |
Ahmed, M.I., M.I. Afifi and I.H. Younos, 2005. Harpagophytum procumbens (Devil's Claw): A possible natural anti-inflammatory agent (An Experimental Study). Iranian J. Pharmacol. Therapeutics, 4: 54-63.
Direct Link |